Page last updated: 2024-11-07

dichlororibofuranosylbenzimidazole and Colorectal Cancer

dichlororibofuranosylbenzimidazole has been researched along with Colorectal Cancer in 1 studies

Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, DM1
Won, M1
Chung, CS1
Kim, S1
Yim, HJ1
Jung, SH1
Jeong, S1

Other Studies

1 other study available for dichlororibofuranosylbenzimidazole and Colorectal Cancer

ArticleYear
JNK-mediated transcriptional upregulation of RhoB is critical for apoptosis of HCT-116 colon cancer cells by a novel diarylsulfonylurea derivative.
    Apoptosis : an international journal on programmed cell death, 2010, Volume: 15, Issue:12

    Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Colorectal Neoplasms; Dich

2010